Apellis Pharmaceuticals, Inc.
Compstatin analogs for treatment of neuropathic pain

Last updated:

Abstract:

In some aspects, the present invention provides methods of treating a subject in need of treatment for neuropathic pain, the method comprising administering a compstatin analog to the subject. In some embodiments, the compstatin analog is administered parenterally, e.g., intravenously.

Status:
Grant
Type:

Utility

Filling date:

9 Jul 2018

Issue date:

30 Jun 2020